Cosmos Health (NASDAQ: COSM) CEO gets 701K shares for $160K debt

Filing Impact

(High)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

Siokas Grigorios reported open-market purchase transactions in this Form 4 filing.

Cosmos Health Inc. Chief Executive Officer Grigorios Siokas acquired 701,447 shares of common stock at $0.2281 per share. Instead of paying cash, the shares were received under a Debt Exchange Agreement dated June 10, 2026, in exchange for $160,000 of debt the company owed him.

Following this transaction, Mr. Siokas directly holds 13,263,361 shares of Cosmos Health common stock. The share price used in the exchange reflects the fair market value of the stock on June 10, 2026, as defined in the agreement.

Insider Trade Summary

Net Buyer: 701,447 shares ($160,000)

Net Buy 1 txn

Insider Siokas Grigorios

Role Chief Executive Officer

Bought 701,447 shs ($160K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $.001	701,447	$0.2281	$160K

Holdings After Transaction: Common Stock, par value $.001 — 13,263,361 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Shares acquired: 701,447 shares Exchange price: $0.2281 per share Debt exchanged: $160,000 +2 more

5 metrics

Shares acquired 701,447 shares Common stock received under Debt Exchange Agreement

Exchange price $0.2281 per share Fair market value on June 10, 2026

Debt exchanged $160,000 Company debt owed to CEO converted into shares

Post-transaction holdings 13,263,361 shares CEO’s direct Cosmos Health common stock after transaction

Buy transactions 1 transaction, 701,447 shares Net-buy direction in transaction summary

Key Terms

Debt Exchange Agreement, Exchange Shares, fair market value, open-market purchase

4 terms

Debt Exchange Agreement financial

"Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"),"

Exchange Shares financial

"these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas"

fair market value financial

"at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.2281 per share, the fair market value of the Common Stock on June 10, 2026,"

The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.

open-market purchase financial

"transaction_action": "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/12/2026 - 06:20 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siokas Grigorios

(Last)

(First)

(Middle)

5 AG. GEORGIOU STR

(Street)

PILEA

THESSALONIKI

TK57001

(City)

(State)

(Zip)

GREECE

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cosmos Health Inc. [ COSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $.001	06/10/2026	06/10/2026	P⁽¹⁾		701,447	A	$0.2281	13,263,361	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), dated as of June 10, 2026, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.2281 per share, the fair market value of the Common Stock on June 10, 2026, in exchange for a total amount of $160,000 in debt the Company owed to Mr. Siokas.

	/s/ Grigorios Siokas	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Cosmos Health (COSM) CEO Grigorios Siokas transact in this Form 4?

Cosmos Health CEO Grigorios Siokas acquired 701,447 common shares. The shares were issued under a Debt Exchange Agreement in exchange for $160,000 of company debt owed to him, using a $0.2281 per-share fair market value.

At what price were the Cosmos Health (COSM) shares valued in the CEO’s exchange?

The shares were valued at $0.2281 per share. This price is described as the fair market value of Cosmos Health common stock on June 10, 2026, as defined in the Debt Exchange Agreement governing the debt-for-equity exchange.

How much debt did Cosmos Health (COSM) exchange with its CEO for shares?

Cosmos Health exchanged $160,000 of debt owed to CEO Grigorios Siokas for common shares. Under the Debt Exchange Agreement, this obligation was converted into 701,447 Exchange Shares valued at $0.2281 per share, eliminating that specific debt balance.

How many Cosmos Health (COSM) shares does the CEO hold after this Form 4 transaction?

After the transaction, CEO Grigorios Siokas directly holds 13,263,361 Cosmos Health common shares. This total reflects his position following the issuance of 701,447 Exchange Shares under the June 10, 2026 Debt Exchange Agreement with the company.

Was the Cosmos Health (COSM) CEO’s Form 4 transaction a cash purchase?

The transaction was not a cash purchase. The CEO received 701,447 Exchange Shares under a Debt Exchange Agreement, canceling $160,000 of company debt owed to him at a fair market value of $0.2281 per share instead of paying cash.